IMAB - I-Mab Biopharma FY 2022 Earnings Preview
2023-03-30 12:47:04 ET
- I-Mab Biopharma ( NASDAQ: IMAB ) is scheduled to announce FY earnings results on Thursday, March 30th, before market open.
- The consensus EPS Estimate is -$0.83 (+46.1% Y/Y) and the consensus Revenue Estimate is $37.13M (+169.1% Y/Y).
- Over the last 1 year, IMAB has beaten EPS estimates 25% of the time and has beaten revenue estimates 50% of the time.
For further details see:
I-Mab Biopharma FY 2022 Earnings Preview